Lb Pharmaceuticals Inc · NASDAQ:LBRX
Commodore Capital LP reported a 5.50% stake in Lb Pharmaceuticals Inc (Schedule 13G)
Event Sep 11, 2025 · Filed Sep 18, 2025
Commodore Capital LP reported a 5.50% stake in Lb Pharmaceuticals Inc, 1,225,000 shares, as a passive investor on Sep 11, 2025. Filed Sep 18, 2025 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 1,225,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 5.50% | 1,225,000 |
| Commodore Capital Master LP | 5.50% | 1,225,000 |
| Robert Egen Atkinson | 5.50% | 1,225,000 |
| Michael Kramarz | 5.50% | 1,225,000 |
Source
Related
- Lb Pharmaceuticals Inc
- Commodore Capital LP
- Lb Pharmaceuticals Inc shareholders
- Schedule 13G/A · Commodore Capital LP · May 15, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 13, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G · JPMorgan Chase & Co · Jul 16, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · May 15, 2026